The Economic Value of a Quadrivalent versus Trivalent Influenza Vaccine

Lee, Bruce Y.; Bartsch, Sarah M.; Willig, Alyssa M.

doi:10.1016/j.vaccine.2012.10.025

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

The Economic Value of a Quadrivalent versus Trivalent Influenza Vaccine

Oct 19 2012
By Lee, Bruce Y. ; Bartsch, Sarah M. ; Willig, Alyssa M.
http://dx.doi.org/10.1016/j.vaccine.2012.10.025
Source: Vaccine. 2012; 30(52):7443-7446.

[PDF-39.54 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Vaccine
Personal Author:

Lee, Bruce Y. ; Bartsch, Sarah M. ; Willig, Alyssa M.

Lee, Bruce Y. ; Bartsch, Sarah M. ; Willig, Alyssa M. Less -
Description:

The recently licensed quadrivalent seasonal influenza vaccine (QIV) may provide better protection than the traditional trivalent influenza vaccine (TIV) as it includes one more influenza B strain. We developed a Monte Carlo simulation model to determine the economic value of a QIV compared to the TIV for 10 influenza seasons (1999-2009). The addition of the influenza B strain to convert the TIV into a QIV could result in substantial cost-savings to society (median of $3.1 billion) and third party payers (median of $292 million), even when the cost of QIV is significantly higher.
Subjects:

[+]

Adolescent Adult Aged Aged, 80 And Over Child Child, Preschool Costs And Cost Analysis Female Humans Infant Influenza, Human Influenza Vaccines Male Middle Aged Young Adult
Source:

Vaccine. 2012; 30(52):7443-7446.
Pubmed ID:

23084849
Pubmed Central ID:

PMC3696129
Document Type:

Journal Article
Funding:

1U54GM088491-0109/GM/NIGMS NIH HHS/United States ; 5P01HK000086-02/HK/PHITPO CDC HHS/United States ; 5R01LM009132-03/LM/NLM NIH HHS/United States ; R01 LM009132/LM/NLM NIH HHS/United States ; U54 GM088491/GM/NIGMS NIH HHS/United States

1U54GM088491-0109/GM/NIGMS NIH HHS/United States ; 5P01HK000086-02/HK/PHITPO CDC HHS/United States ; 5R01LM009132-03/LM/NLM NIH HHS/United States ; R01 LM009132/LM/NLM NIH HHS/United States ; U54 GM088491/GM/NIGMS NIH HHS/United States Less -
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:92d9ed62e7f9929cc8bd3af7f36d66415b50bd6d2670d55c68339b44495d1e09
Download URL:

https://stacks.cdc.gov/view/cdc/33590/cdc_33590_DS1.pdf
File Type:

nihms414862.nxml

bin

More +